GSK PLC
NYSE:GSKHealthcare$49.46−0.10%At closeAt close · Tue 20 Oct · ≈ AED 181.64 · Market cap $99.47B · Next earnings Wed 28 Oct
What sells — revenue by segment
100%—
Share of FY2022 revenue · growth vs FY2021
Where it sells — revenue by region
55%—
45%—
Share of FY2025 revenue · growth vs FY2024
Segments as reported
| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| International | Region | 2025 | GBP | 8,275.0 | 54.7% |
| Europe | Region | 2025 | GBP | 6,850.0 | 45.3% |
| UNITED STATES | Region | 2024 | GBP | 16,384.0 | 53.4% |
| Rest Of World | Region | 2024 | GBP | 14,284.0 | 46.6% |
| UNITED STATES | Region | 2023 | GBP | 15,820.0 | 53.4% |
| Rest Of World | Region | 2023 | GBP | 13,815.0 | 46.6% |
| UNITED STATES | Region | 2022 | GBP | 14,542.0 | 50.8% |
| Rest Of World | Region | 2022 | GBP | 14,087.0 | 49.2% |
| Rest Of World | Region | 2021 | GBP | 18,046.0 | 54.5% |
| UNITED STATES | Region | 2021 | GBP | 15,093.0 | 45.5% |
| UNITED STATES | Region | 2020 | GBP | 14,556.0 | 100.0% |
| Sub Total | Product | 2022 | GBP | 8,960.0 | 100.0% |
| New And Speciality | Product | 2021 | GBP | 9,972.0 | 100.0% |
Revenue by product and region · reported currencyUpdated 31 Dec 2025 ·
ⓘ
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
